These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 5092965

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Determination of decomposition of tablets and dragées].
    Naumchik GN, Zubkova NK, Efimova LS, Rozentsveĭg PE.
    Farmatsiia; 1968; 17(1):22-7. PubMed ID: 5706491
    [No Abstract] [Full Text] [Related]

  • 24. The impact of space travel on dosage form design and use.
    Aronsohn A, Brazeau G, Hughes J.
    J Gravit Physiol; 1999 Jul; 6(1):P169-72. PubMed ID: 11543006
    [Abstract] [Full Text] [Related]

  • 25. [Biologic availability and pharmacokinetics in laboratory animals].
    Tamassia V.
    Boll Chim Farm; 1973 May; 112(5):291-300. PubMed ID: 4761106
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.
    Withey RJ, Feng H, Cook D, Van Petten GR, Lettau HF.
    J Clin Pharmacol New Drugs; 1971 May; 11(3):187-96. PubMed ID: 5211352
    [No Abstract] [Full Text] [Related]

  • 30. [The biological availability of several digoxin preparations used in the Netherlands].
    Dunning AJ, Buurke EJ, Roos JC, Paalman AC, van Rooy HH.
    Ned Tijdschr Geneeskd; 1973 Dec 01; 117(48):1809-16. PubMed ID: 4788673
    [No Abstract] [Full Text] [Related]

  • 31. Biopharmaceutics and applied pharmacy.
    Krówczyński L.
    Pharmazie; 1971 Nov 01; 26(11):659. PubMed ID: 5154316
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Pharmacokinetic aspects relevant to biopharmaceutics].
    Segre G.
    Ann Ist Super Sanita; 1982 Nov 01; 18(3):533-40. PubMed ID: 7187841
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The physiologic availability of solid dosage forms of phenylbutazone. I. In vivo physiologic availability and pharmacologic considerations.
    Van Petten GR, Feng H, Withey RJ, Lettau HF.
    J Clin Pharmacol New Drugs; 1971 Nov 01; 11(3):177-86. PubMed ID: 5211351
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1980 Nov 01; 645():1-54. PubMed ID: 6774485
    [No Abstract] [Full Text] [Related]

  • 39. [Biopharmacy and pharmacokinetics].
    Janků I.
    Pharmazie; 1971 Nov 01; 26(11):660. PubMed ID: 5154317
    [No Abstract] [Full Text] [Related]

  • 40. [Pharmaceutical analysis of 9,9-dioxopromethazine hydrochloride (Prothanon)].
    Mayer W, Erbe S.
    Pharmazie; 1970 Feb 02; 25(2):84-7. PubMed ID: 5422145
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.